Agilent Presents Thought Leader Award to Professor Jason Kovacic
January 10, 2022
Victor Chang Cardiac Research Institute (VCCRI) researcher recognized for his influential work on cardiovascular disease SANTA CLARA, Calif. -- Agilent Technologies Inc. (NYSE: A) today announced that Professor Jason Kovacic has been selected to receive a prestigious Agilent Thought Leader Award. Professor Kovacic is being recognized for his influential research on cardiovascular disease—specifically the pathobiology of vascular diseases, [...]
January 10, 2022
-- Reveals Plug and Play, Low Cost, No Scar, Scalable Enzymatic Synthesis 3.0 -- -- Partners with PacBio, Singular Genomics Enabling New Sequencing Platforms -- SOUTH SAN FRANCISCO, Calif. -- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that it [...]
January 10, 2022
Delivery of 100,000 samples of capacity annually to the market, empowering genomics researchers to add deep, unbiased proteomics analysis to their studies REDWOOD CITY, Calif. and HUNTSVILLE, Ala. and FRAMINGHAM, Mass. -- Seer Inc. (NASDAQ: SEER), a life sciences company commercializing a disruptive new platform for proteomics; SCIEX, a global leader in life science analytical [...]
January 10, 2022
Amsterdam, the Netherlands – LUMICKS, a next generation life science tools provider, today announced that two major centers of excellence in cancer immunology have adopted LUMICKS’ z-Movi® Cell Avidity Analyzer instrument. The first placement is at Fred Hutchinson Cancer Research Center (“Fred Hutch”) in Seattle, Washington, USA, a leading research institute dedicated to the eradication of cancer. The instrument [...]
January 10, 2022
(Peabody, MA) - A new Scanning Electron Microscope (SEM) from JEOL answers the need for faster and easier acquisition of both SEM images and EDS data analysis, especially suited for repetitive operations and quality control. JEOL, the global leader in the development of cutting-edge Electron Microscopes for materials characterization and analysis, introduces its latest SEM, the [...]
Executive Team Hires at SOPHiA GENETICS to Enhance BioPharma Business
January 10, 2022
BOSTON and LAUSANNE, Switzerland -- SOPHiA GENETICS SA (Nasdaq: SOPH), the creator of a global data pooling and knowledge sharing platform that advances data-driven medicine, announced key additions to their leadership team with the hiring of Peter Casasanto as Chief BioPharma Officer and Abhimanyu (Abhi) Verma as Chief Technology Officer. The additions are part of [...]
NanoString Announces Commercial Leadership Transition
January 9, 2022
Chad Brown to Retire Following More than Four Successful Years as SVP, Sales & Marketing Genomics and Diagnostics Veteran John D. Gerace Appointed as Chief Commercial Officer SEATTLE -- NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced a commercial leadership transition. Chad Brown, who has [...]
January 9, 2022
Superhero cells are key to the efficacy, potency, and durability of therapies across the human health spectrum BRANFORD, Conn. -- IsoPlexis (NASDAQ: ISO), the Superhuman Cell Company, today announced its preliminary unaudited revenue for the full year 2021. Total revenue for 2021 is expected to be in the range of $17.0 to $17.2 million, representing an increase of [...]
January 9, 2022
LOS ANGELES -- Calibre Scientific is pleased to announce the acquisition of Medline Scientific, a distributor of laboratory consumables and equipment with headquarters in Oxfordshire, United Kingdom. Medline Scientific further enhances Calibre Scientific’s growing distribution presence in the United Kingdom. Medline Scientific is a premier distributor of laboratory products to a broad range of domestic [...]
OriGene Technologies Updates Logo for Rebranding Its Expansion from Genomics to Proteomics
January 7, 2022
ROCKVILLE, Md. -- OriGene updates its logo, signifying its evolvement from genomic to proteomic market. The logo modification includes an addition of antibody/antigen image to the previous logo, highlighting the expansion of OriGene's product portfolio from genomic (plasmids/RNAi/PCR) to proteomic (protein/antibody/assays). In the past 25 years, OriGene has dedicated to creation of the world's largest source of [...]

